Literature DB >> 27541320

An Ethics of Permission: A Response to the California End of Life Option Act.

Craig Nelson1.   

Abstract

An ethics of permission can be helpful in framing a response to the ethical differences surrounding the California End of Life Option Act. Law does not define morality, and reaching a moral understanding demands thorough reflection. An ethics of permission examines the ethical demands of a permissive law for both clinician and patient. Serving the good of the patient, respecting professional conscience, and following the law are three ethical elements. Although developing an ethics of permission includes these three elements, these elements do not exhaust all the moral implications involved. An ethics of permission also includes the importance of exercising professional tolerance in the honoring of clinicians who choose to participate or refuse to participate. In addition, an ethics of permission also provides insight in implementing just and fair behavior among medical professionals.

Entities:  

Mesh:

Year:  2016        PMID: 27541320      PMCID: PMC5101103          DOI: 10.7812/TPP/16-023

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  5 in total

1.  Unfair? It depends: neural correlates of fairness in social context.

Authors:  Berna Güroğlu; Wouter van den Bos; Serge A R B Rombouts; Eveline A Crone
Journal:  Soc Cogn Affect Neurosci       Date:  2010-03-28       Impact factor: 3.436

Review 2.  What's fair? The unconscious calculus of our moral faculty.

Authors:  Marc Hauser
Journal:  Novartis Found Symp       Date:  2007

3.  Some things ought never be done: moral absolutes in clinical ethics.

Authors:  Edmund D Pellegrino
Journal:  Theor Med Bioeth       Date:  2005

4.  Keeping moral space open. New images of ethics consulting.

Authors:  M U Walker
Journal:  Hastings Cent Rep       Date:  1993 Mar-Apr       Impact factor: 2.683

5.  Physicians should "assist in suicide" when it is appropriate.

Authors:  Timothy E Quill
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.